The short version
12 companies supply this market — deep enough that no single failure threatens the supply. The price has held steady around $0.1625 per mL over the past year. A Class II recall hit this product in the past year (Bell Pharmaceuticals, Inc). Put together: this looks like a healthy supply — the boring kind, which is exactly what you want. Historically, drugs in this position went on to a new shortage within 90 days about 0.2% of the time — roughly 2× the typical drug (0.1%).
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.